SCHEMBL5284684

SCHEMBL5284684

CCC[n+]1ccn(-c2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
GLA P06280 1/20 0.39
PKM P14618 1/20 0.39
MAPT P10636 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
APAF1 O14727 1/20 0.37
MITF O75030 1/20 0.37
PABPC1 P11940 1/20 0.35
RXFP1 Q9HBX9 2/20 0.35
BLM P54132 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5817533 0.90 KDM4E (0.49) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL12153431 0.89 MEN1 (0.47) MEN1KMT2AKDM4EALDH1A1HPGD
Iodide SCHEMBL15992661 0.88 KDM4E (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5297789 0.88 KDM4E (0.50) MEN1KMT2AKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL27914237 0.88 KDM4E (0.48) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5295539 0.87 KDM4E (0.49) KMT2AKDM4EGLAPKMHTT
SCHEMBL5297432 0.87 KDM4E (0.49) KMT2AKDM4EGLAPKMHTT
SCHEMBL5810521 0.87 KDM4E (0.49) KMT2AKDM4EGLAPKMHTT
SCHEMBL5301618 0.87 KDM4E (0.49) KMT2AKDM4EGLAPKMHTT
SCHEMBL5816934 0.87 KDM4E (0.49) KMT2AKDM4EGLAPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
CN-112703184-A Process for producing amide compound, and amide compound 广荣化学株式会社 2021-04-23 CN disclosed
WO-2020152206-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-07-30 WO disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM MEN1 55/4885KMT2A 4207/4885KDM4E 4058/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM MEN1 55/4885KMT2A 4207/4885KDM4E 4058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.